Accomplished molecular microbiologist and protein engineer takes charge of CSIR-IMTECH after serving in key scientific and regulatory leadership roles at FSSAI
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities
Preclinical CRO strengthens leadership team with key executive appointments as it scales its human tissue-based drug discovery platform
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
Veteran pharma and biotech executive brings over 20 years of commercial leadership experience to support LMS's global CDMO and API growth strategy
Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
The graduating cohort comprised seven batches across five specialized programs
The newly commissioned facility strengthens the ’company’s capabilities in the development and manufacturing of generic and complex sterile injectable products
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
